Tumor-associated macrophages in lung carcinoma: From mechanism to therapy

Xueying Wang1, Yining Wu1, Jiahui Gu1

  • 1Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Insights

Tumor-associated macrophages (TAMs) promote lung cancer progression and metastasis. Targeting these macrophages presents a promising therapeutic strategy for lung cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Tumor-associated macrophages (TAMs) are key components of the lung cancer microenvironment.
  • TAMs can be classified into M1-like and M2-like phenotypes, with M2-like TAMs often associated with tumor promotion.

Purpose of the Study:

  • To review the fundamental characteristics of TAMs.
  • To elucidate the role of TAMs in lung cancer metastasis.
  • To present evidence supporting TAMs as potential therapeutic targets in lung cancer.

Main Methods:

  • Literature review of studies on TAMs in lung cancer.
  • Analysis of TAM phenotypes (M1/M2) and their correlation with prognosis.
  • Examination of TAM functions in tumor initiation, immune evasion, angiogenesis, and metastasis.

Main Results:

  • TAMs are frequently associated with poor prognosis in lung cancer patients.
  • TAMs contribute to tumor cell proliferation, immune suppression, and angiogenesis.
  • TAMs play a significant role in promoting lung carcinoma metastasis.

Conclusions:

  • TAMs are critical drivers of lung cancer progression and metastasis.
  • Targeting TAMs offers a potential novel therapeutic avenue for lung cancer treatment.

Related Concept Videos